BAYER AG |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 29.06 EUR | -1.11% |
|
+3.00% | -12.76% |
| 09:38am | Bayer: core EPS down 4% in Q1 | CF |
| 08:34am | CAC 40: caution ahead of a series of indicators | CF |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 47.09B 50.79B | Sales 2025 * | 47.95B 51.72B | Capitalization | 28.86B 31.13B |
|---|---|---|---|---|---|
| Net income 2024 * | 2.08B 2.24B | Net income 2025 * | 3.17B 3.42B | EV / Sales 2024 * | 1.32 x |
| Net Debt 2024 * | 33.1B 35.7B | Net Debt 2025 * | 29.67B 32B | EV / Sales 2025 * | 1.22 x |
| P/E ratio 2024 * |
13.4
x | P/E ratio 2025 * |
9.04
x | Employees | 96,931 |
| Yield 2024 * |
0.38% | Yield 2025 * |
0.79% | Free-Float | 99.97% |
More Fundamentals
* Assessed data
More news
Latest transcript on Bayer AG
More press releases
More news
| 1 day | -1.01% | ||
| 1 week | +3.56% | ||
| Current month | +7.86% | ||
| 1 month | +11.49% | ||
| 3 months | +5.09% | ||
| 6 months | -27.41% | ||
| Current year | -12.28% |
1 week
28.25
30.30
1 month
25.6130.30
Current year
24.9636.09
1 year
24.9654.95
3 years
24.9667.99
5 years
24.9678.34
10 years
24.96146.45
| Managers | Title | Age | Since |
|---|---|---|---|
William Anderson
CEO | Chief Executive Officer | 57 | 23-03-31 |
| Director of Finance/CFO | 55 | 18-04-25 | |
Bijoy Sagar
CTO | Chief Tech/Sci/R&D Officer | 55 | 20-03-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Colleen Goggins
BRD | Director/Board Member | 68 | 17-03-31 |
Alberto Weisser
BRD | Director/Board Member | 67 | 21-03-31 |
Paul Achleitner
BRD | Director/Board Member | 67 | 02-03-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 9.77% | 70 M€ | -.--% | - | |
| 5.71% | 2 M€ | +13.56% | - | |
| 4.28% | 962 M€ | -.--% | - | |
| 4.10% | 0 M€ | 0.00% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-14 | 29.38 | 0.00% | 1 427 865 |
| 24-05-13 | 29.38 | +1.47% | 3,538,582 |
| 24-05-10 | 28.96 | +0.92% | 3,655,535 |
| 24-05-09 | 28.69 | +0.76% | 1,997,631 |
| 24-05-08 | 28.48 | -0.04% | 2,244,692 |
Delayed Quote Xetra, May 14, 2024 at 03:40 am EDT
More quotes
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows:
- agrochemicals (48.8%): herbicides, fungicides, insecticides, etc.;
- pharmaceutical products (38%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.;
- OTC products and nutritional supplements (12.7%);
- other (0.5%).
Net sales are distributed geographically as follows: Germany (5.1%), Switzerland (1.2%), Europe-Middle East-Africa (23.2%), the United States (30.6%), North America (3.5%), China (7.6%), Asia-Pacific (10%), Brazil (10.4%) and Latin America (8.4%).
Sector
Pharmaceuticals
Calendar
01:30am
- Q1 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
29.38
EUR
Average target price
36.9
EUR
Spread / Average Target
+25.61%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -12.28% | 31.15B | |
| +29.98% | 682B | |
| +31.74% | 586B | |
| -3.52% | 364B | |
| +18.59% | 327B | |
| +4.07% | 285B | |
| +16.51% | 240B | |
| +9.45% | 209B | |
| -8.75% | 203B | |
| +7.09% | 165B |
- Stock Market
- Equities
- BAYN Stock
